Seletracetam
Jump to navigation
Jump to search
| File:Seletracetam.svg | |
| File:Seletracetam3d.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Routes of administration | Oral |
| Physiological data | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | >90% |
| Elimination half-life | 8h |
| Identifiers | |
| |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C10H14F2N2O |
| Molar mass | 232.227 |
| 3D model (JSmol) | |
| |
Seletracetam is a drug of the racetam family. It is currently being developed by UCB Pharmaceuticals as an anticonvulsant drug. While similar in structure to so-called nootropic drugs, it is not expected to have cognitive enhancing properties.
See also
 | This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Articles with short description
- Pages with broken file links
- Drugs with non-standard legal status
- Pages using infobox drug with unknown parameters
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Articles containing unverified chemical infoboxes
- Anticonvulsant stubs
- Racetams